Standard Biotools (LAB) Retained Earnings (2016 - 2025)
Standard Biotools (LAB) has disclosed Retained Earnings for 16 consecutive years, with -$477000.0 as the latest value for Q3 2025.
- On a quarterly basis, Retained Earnings rose 66.15% to -$477000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$477000.0, a 66.15% increase, with the full-year FY2024 number at -$1.2 billion, down 18.48% from a year prior.
- Retained Earnings was -$477000.0 for Q3 2025 at Standard Biotools, up from -$1.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$477000.0 in Q3 2025 to a low of -$1.2 billion in Q1 2025.
- A 5-year average of -$451.7 million and a median of -$2.6 million in 2022 define the central range for Retained Earnings.
- Peak YoY movement for Retained Earnings: skyrocketed 99.89% in 2021, then tumbled 102005.4% in 2022.
- Standard Biotools' Retained Earnings stood at -$907000.0 in 2021, then crashed by 102005.4% to -$926.1 million in 2022, then fell by 8.06% to -$1.0 billion in 2023, then dropped by 18.48% to -$1.2 billion in 2024, then skyrocketed by 99.96% to -$477000.0 in 2025.
- Per Business Quant, the three most recent readings for LAB's Retained Earnings are -$477000.0 (Q3 2025), -$1.9 million (Q2 2025), and -$1.2 billion (Q1 2025).